| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| G3335 |
H-TRP-GLU-OH |
36099-95-3 |
詳細(xì)
|
| Zabicipril HCl |
扎普利 |
90130-77-1 |
詳細(xì)
|
| CAY10721 |
2-([1]benzofuro[3,2-d]pyrimidin-4-ylsulfanyl)-N-(3-hydroxyphenyl)acetamide |
848688-62-0 |
詳細(xì)
|
| MAGL-IN-5 |
CAY10499 |
359714-55-9 |
詳細(xì)
|
| CX717 |
苯并[C][1,2,5]惡二唑-5-基(嗎啉)甲酮 |
867276-98-0 |
詳細(xì)
|
| Muramic acid HCl |
MURAMIC ACID 鹽酸鹽 |
55226-93-2 |
詳細(xì)
|
| EBOV-IN-1 |
EBOV抑制劑1 |
1335113-30-8 |
詳細(xì)
|
| Sulpho NONOate |
DISODIUM (E)-1-SULFONATODIAZEN-1-IUM-1,2-DIOLATE |
61142-90-3 |
詳細(xì)
|
| O-Succinylhomoserine |
O-SUCCINYL-L-HOMOSERINE |
1492-23-5 |
詳細(xì)
|
| MeTC7 |
(2S,4AR,4BR,6AR,7R,9AR)-4A,6A,12-三甲基-7-((R)-6-甲基庚-2-基)-11,13-二氧代-2,3,4,4A,4B,5,6,6A,7,8,9,9A,12,13-十四氫-1H,11H-9B,14A-乙橋苯并[C]環(huán)戊二烯并[H][1,2,4]三唑并[1,2-A]噌啉-2-基 2-溴乙酸酯 |
1817841-22-7 |
詳細(xì)
|
| N-acetyl Dapsone |
N-乙酰氨苯砜 |
565-20-8 |
詳細(xì)
|
| Stephacidin B |
STEPHACIDIN B |
360765-75-9 |
詳細(xì)
|
| IHMT-PI3Kδ-372 |
化合物IHMT-PI3KΔ-372 |
2429889-62-1 |
詳細(xì)
|
| D-NMAPPD |
(1R,2R)-B13 |
35922-06-6 |
詳細(xì)
|
| BRD0418 |
化合物 T30577 |
1565827-99-7 |
詳細(xì)
|
| Cyclo(L-Pro-L-Val) |
環(huán)(L-脯-L-纈)二肽 |
2854-40-2 |
詳細(xì)
|
| 3-Hydroxypropionic Acid sodium salt |
3-Hydroxypropionic acid sodium salt |
6487-38-3 |
詳細(xì)
|
| Ametoctradin |
唑嘧菌胺 |
865318-97-4 |
詳細(xì)
|
| Ardisiacrispin A |
百兩金素 |
23643-61-0 |
詳細(xì)
|
| 17β-Estradiol sulfate sodium |
BETA-雌二醇 3-硫酸鈉鹽 |
4999-79-5 |
詳細(xì)
|
| S2H97 |
|
|
詳細(xì)
|
| BMP-4 Protein, Human, Recombinant (E399D) |
BMP4, HUMAN, 重組蛋白 (E399D) |
|
詳細(xì)
|
| [Tyr3]Octreotate |
[Tyr3]Octreotate acetate |
302794-43-0 |
詳細(xì)
|
| MRS 2905 |
|
|
詳細(xì)
|
| AHR Inhibitor I-103 |
AHR 抑制劑 I-103 |
2247951-12-6 |
詳細(xì)
|
| (S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide |
化合物 (S)-4-METHYL-N-(3-(4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-2-(PYRIMIDIN-5-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOXAMIDE |
1934246-20-4 |
詳細(xì)
|
| Atacicept |
阿塞西普 |
845264-92-8 |
詳細(xì)
|
| HCV-IN-31 |
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
1998705-62-6 |
詳細(xì)
|
| Demcizumab |
Demcizumab |
1243262-17-0 |
詳細(xì)
|
| 2′,2′-Difluorodeoxyuridine |
2'-脫氧-2',2'-二氟尿嘧啶核苷 |
114248-23-6 |
詳細(xì)
|
| MERS-CoV Spike/S1 Protein (aa 1-725, His) |
MERS-COV SPIKE/S1 重組蛋白 (AA 1-725, HIS) |
|
詳細(xì)
|
| MCTR2 |
MCTR2 |
1784701-62-7 |
詳細(xì)
|
| Fibrinogen |
纖維蛋白原 |
9001-32-5 |
詳細(xì)
|
| 2,4-Diacetylphloroglucinol |
2,4-二乙酰基間苯三酚 |
2161-86-6 |
詳細(xì)
|
| (±)9-HEPE |
(+/-)-9-HYDROXY-5Z,7E,11Z,14Z,17Z-EICOSAPENTAENOIC ACID |
286390-03-2 |
詳細(xì)
|
| NAE-IN-M22 |
化合物NAE-IN-M22 |
864420-54-2 |
詳細(xì)
|
| JI6 |
JAK3 INHIBITOR VI |
856436-16-3 |
詳細(xì)
|
| FiVe1 |
FiVe1 |
932359-76-7 |
詳細(xì)
|
| KYP-2047 |
KYP-2047;KYP 2047;KYP2047 |
796874-99-2 |
詳細(xì)
|
| H-D-Phe-Pip-Arg-pNA dihydrochloride |
化合物H-D-PHE-PIP-ARG-PNA DIHYDROCHLORIDE |
62354-65-8 |
詳細(xì)
|
| 4'-Methoxyflavanone |
)-4'-甲氧基黃烷酮 |
97005-76-0 |
詳細(xì)
|
| Soticlestat |
TAK-935 |
1429505-03-2 |
詳細(xì)
|
| IACS-13909 |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
詳細(xì)
|
| 20-HEPE |
20-HEPE |
116477-57-7 |
詳細(xì)
|
| N-phenylthiophene-2-carboximidamide |
2-Thiophenecarboximidamide, N-phenyl- |
3737-39-1 |
詳細(xì)
|
| 5-Octyl-α-ketoglutarate |
5-Octyl-α-ketoglutarate |
1616344-00-3 |
詳細(xì)
|
| AVN 322 free base |
化合物 AVN 322 FREE BASE |
1194574-33-8 |
詳細(xì)
|
| ALR2-IN-1 |
2-(2-羥基-5-甲基亞芐基)-N-(3-甲氧基苯基)肼-1-硫代甲酰胺 |
2799695-54-6 |
詳細(xì)
|
| CAY10464 |
CAY10464 |
688348-37-0 |
詳細(xì)
|
| Resolvin E2 |
Resolvin E2 |
865532-70-3 |
詳細(xì)
|
| Cerlapirdine |
SAM-531 |
925448-93-7 |
詳細(xì)
|
| 12-oxo Leukotriene B4 |
(5S,6Z,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid |
136696-10-1 |
詳細(xì)
|
| VEGFR2-IN-2 |
4-((4-溴芐基)氧基)喹唑啉 |
737818-56-3 |
詳細(xì)
|
| CP-91149 |
5-氯-N-[(1S,2R)-3-(二甲基氨基)-2-羥基-3-氧代-1-(苯基甲基)丙基]-1H-吲哚-2-甲酰胺 |
186392-40-5 |
詳細(xì)
|
| NBC 19 |
NBC19 |
2068818-75-5 |
詳細(xì)
|
| G3-C12 acetate(848301-94-0 free base) |
化合物G3-C12 ACETATE |
|
詳細(xì)
|
| 6α-Hydroxy-5α-cholestane |
6Α-HYDROXY-5Α-CHOLESTANE;6Α-HYDROXY-5Α-CHOLESTANOL |
41083-73-2 |
詳細(xì)
|
| CP 465022 |
CP 465022 HYDROCHLORIDE |
199655-36-2 |
詳細(xì)
|
| Dazonone |
化合物T9871 |
105622-85-3 |
詳細(xì)
|
| TAPI1 |
163847-77-6 |
163847-77-6 |
詳細(xì)
|
| Etidocaine |
益替多卡因 |
36637-18-0 |
詳細(xì)
|
| Speract TFA(76901-59-2(free base)) |
化合物SPERACT TFA |
|
詳細(xì)
|
| BW A868C |
3-[(2-環(huán)己基-2-羥乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸 |
118675-50-6 |
詳細(xì)
|
| JMJD6 inhibitor WL12 |
3-(3H-咪唑并[4,5-C]吡啶-2-基)-6-甲基-2H-苯并吡喃-2-酮 |
899548-78-8 |
詳細(xì)
|
| WEE1-IN-3 |
JUN76288 |
2272976-28-8 |
詳細(xì)
|
| LEM-14 |
化合物 T9006 |
1814881-70-3 |
詳細(xì)
|
| CXCL-CXCR1/2-IN-1 |
CXCL-CXCR1/2 抑制劑 1 |
2415653-55-1 |
詳細(xì)
|
| Compound CDy9 |
3,4-二甲氧基-N-(3-氨磺酰基苯基)苯甲酰胺 |
952306-80-8 |
詳細(xì)
|
| 5-Ethynyluridine |
5-乙炔基尿苷 |
69075-42-9 |
詳細(xì)
|
| GDF-15 Protein, Mouse, Recombinant (hFc) |
GDF-15, MOUSE, 重組蛋白 (HFC) |
|
詳細(xì)
|
| BMY-14802 |
alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol |
105565-56-8 |
詳細(xì)
|
| (R)-Mephenytoin |
美芬妥英 |
71140-51-7 |
詳細(xì)
|
| SIGIRR Protein, Human, Recombinant (His) |
SIGIRR, HUMAN, 重組蛋白 (HIS) |
|
詳細(xì)
|
| (±)19(20)-DiHDTE |
|
|
詳細(xì)
|
| Sericoside |
齊墩果酸 BETA-D-葡萄糖酯 |
55306-04-2 |
詳細(xì)
|
| MK-0249 FA |
MK-0249 甲酸鹽 |
|
詳細(xì)
|
| ENT-C225 |
化合物 ENT-C225 |
2919962-53-9 |
詳細(xì)
|
| 17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid |
17-keto-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid Exclusive |
1233715-33-7 |
詳細(xì)
|
| CLEFMA |
4-[3,5-Bis[(2-chlorophenyl)methylene]-4-oxo-1-piperidinyl]-4-oxo-2-butenoic acid |
1246964-32-8 |
詳細(xì)
|
| Ianalumab |
Ianalumab |
1929549-92-7 |
詳細(xì)
|
| Tepotinib hydrochloride(1 : x) |
化合物TEPOTINIB HYDROCHLORIDE(1 : X) |
1103508-80-0 |
詳細(xì)
|
| JAK1/2/3 Inhibitor 1 |
2,4-二氯噻吩并[3,2-D]嘧啶 |
16234-14-3 |
詳細(xì)
|
| Lats-IN-1 |
1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, N-[3-(phenylmethyl)-2(3H)-thiazolylidene]- |
1424635-83-5 |
詳細(xì)
|
| OX40/TNFRSF4 Protein, Human, Recombinant (His) |
OX40/TNFRSF4, HUMAN, 重組蛋白 (HIS) |
|
詳細(xì)
|
| SORT-PGRN interaction inhibitor 1 |
1-芐基-3-叔丁基-1H-吡唑-5-羧酸 |
100957-85-5 |
詳細(xì)
|
| BGT226 |
BGT226 |
915020-55-2 |
詳細(xì)
|
| Celosin H |
青葙苷H |
1623405-28-6 |
詳細(xì)
|
| 2-(1-methyl-1H-imidazol-4-yl)acetic acid |
2-(1-甲基-1H-咪唑-4-基)乙酸 |
2625-49-2 |
詳細(xì)
|
| Globotetraosylceramides (porcine RBC) |
紅細(xì)胞糖苷脂 |
11034-93-8 |
詳細(xì)
|
| Bemnifosbuvir |
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester |
1998705-64-8 |
詳細(xì)
|
| Ciprostene (calcium salt) |
6,9ALPHA-METHYLENE-9BETA-METHYL-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID, CALCIUM SALT |
81703-55-1 |
詳細(xì)
|
| TLR7 agonist 3 |
TLR7 AGONIST 3 |
1229024-78-5 |
詳細(xì)
|
| WAY-620521 |
N-(萘-2-基)-2,3-二氫苯并[B][1,4]二噁烷-6-磺酰胺 |
315693-33-5 |
詳細(xì)
|
| Carboxyebselen |
CARBOXYEBSELEN |
153871-75-1 |
詳細(xì)
|
| Aureusidin |
金色草素 |
38216-54-5 |
詳細(xì)
|
| NSC45586 |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
詳細(xì)
|
| Pomalidomide-PEG2-NH2 hydrochloride |
POMALIDOMIDE-PEG2-NH2鹽酸鹽 |
|
詳細(xì)
|
| MY10 |
化合物 MY10 |
2204270-73-3 |
詳細(xì)
|
| (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid |
化合物T77548 |
89667-39-0 |
詳細(xì)
|
| MC2590 |
化合物 MC2590 |
2284460-01-9 |
詳細(xì)
|